BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2664751)

  • 1. Renal function studies with cadralazine in conscious dogs: a comparison with hydralazine.
    Ferni G; Bonardi G; Lombroso M; Semeraro C; Dorigotti L
    Pharmacol Res; 1989; 21(2):211-22. PubMed ID: 2664751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cadralazine on systemic blood pressure, renal function and plasma renin activity in anesthetized dogs.
    Yukimura T; Miura K; Tanaka M; Higashio T; Sakaguchi S; Kuroda K; Yamamoto K
    Arzneimittelforschung; 1988 Jan; 38(1):25-8. PubMed ID: 3284531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive activity of cadralazine in experimental hypertensive rats.
    Takeyama K; Ikeno A; Minato H; Fukuya F; Nishimura S; Hosoki K; Kadokawa T
    Arch Int Pharmacodyn Ther; 1988; 291():163-74. PubMed ID: 3365060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological studies on cadralazine: a new antihypertensive vasodilator drug.
    Semeraro C; Dorigotti L; Banfi S; Carpi C
    J Cardiovasc Pharmacol; 1981; 3(3):455-67. PubMed ID: 6168827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of the novel arteriovenous dilator agent, flosequinan in conscious dogs and cats.
    Sim MF; Yates DB; Parkinson R; Cooling MJ
    Br J Pharmacol; 1988 Jun; 94(2):371-80. PubMed ID: 3293682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of cadralazine in hexamethonium treated and non-treated anesthetized dogs.
    Higashio T; Tsuji Y; Nakao K; Sakaguchi S; Tanaka M
    Arzneimittelforschung; 1988 Mar; 38(3):350-8. PubMed ID: 3382459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pinacidil on renal hemodynamics and function in anesthetized dogs.
    Morimoto S; Sasaki Y; Matsumura Y
    J Pharmacobiodyn; 1986 Feb; 9(2):146-55. PubMed ID: 3519923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic profile of the antihypertensive vasodilator cadralazine in conscious dogs.
    Dorigotti L; Ferni G; Lombroso M; Semeraro C
    Arzneimittelforschung; 1984; 34(9):984-7. PubMed ID: 6542375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute systemic and renal haemodynamic effects and long-term antihypertensive action of cadralazine in patients pretreated with beta-blockers and diuretics.
    Persson B; Granerus G; Wysocki M; Hedner T; Andersson OK
    Eur J Clin Pharmacol; 1987; 31(5):513-8. PubMed ID: 2881788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal function studies with propildazine alone and in combination with propranolol in dogs.
    Dorigotti L; Semeraro C
    Eur J Pharmacol; 1980 Oct; 67(2-3):275-82. PubMed ID: 7461034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of combined vasodilation and beta-adrenoceptor blockade with prizidilol on renal function.
    Boehringer K; Weidmann P; Link L; Bianchetti MG; Schiffl H; Reubi FC
    Br J Clin Pharmacol; 1983 Feb; 15(2):181-8. PubMed ID: 6133543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 14 years of antihypertensive treatment on renal function and urinary albumin excretion in primary hypertension.
    Siewert-Delle A; Ljungman S; Hartford M; Wikstrand J
    Am J Hypertens; 1996 Sep; 9(9):841-9. PubMed ID: 8879339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of felodipine on renal function in animals.
    DiBona GF
    Drugs; 1985; 29 Suppl 2():168-75. PubMed ID: 3987545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium entry blockers: antihypertensive and natriuretic effects in experimental animals.
    Nagao T; Yamaguchi I; Narita H; Nakajima H
    Am J Cardiol; 1985 Dec; 56(16):56H-61H. PubMed ID: 3878075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparsion of the effects of prazosin and hydrallazine on blood pressure, heart rate and plasma renin activity in conscious renal hypertensive dogs.
    Massingham R; Hayden ML
    Eur J Pharmacol; 1975 Jan; 30(1):121-4. PubMed ID: 1122933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of cadralazine on the respiration, circulation, kidney, autonomic nervous system, digestive system, blood and so on].
    Nishimori T; Nishimura T; Kobayashi F; Nakano D; Fukuda Y; Sakonjyo H; Nakanishi J; Kimura A; Tsuji H; Higashio T
    Nihon Yakurigaku Zasshi; 1988 Apr; 91(4):221-36. PubMed ID: 3391446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparisons of the depressor, inotropic and renal effects of milrinone and CI-930 to different pure vasodilators and diuretics in conscious instrumented dogs.
    Lee KC; Clas DM; Gorczyca WP; Silver PJ; Ezrin AM
    Drugs Exp Clin Res; 1991; 17(7):323-36. PubMed ID: 1686584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanism of the acute antihypertensive and vasodilator actions of several beta-adrenoceptor antagonists.
    Sybertz EJ; Baum T; Pula KK; Nelson S; Eynon E; Sabin C
    J Cardiovasc Pharmacol; 1982; 4(5):749-58. PubMed ID: 6182405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: a comparison with hydralazine.
    Velasco M; Gilbert CA; Rutledge CO; McNay JL
    Clin Pharmacol Ther; 1975 Aug; 18(2):145-53. PubMed ID: 1097150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term hypotensive and renal effects of atrial natriuretic peptide.
    Granger JP; Opgenorth TJ; Salazar J; Romero JC; Burnett JC
    Hypertension; 1986 Jun; 8(6 Pt 2):II112-6. PubMed ID: 2941368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.